Marco in the patient chart — Clinical decision support in oncology

Evidence that already knows the patient.

Marco lives inside the patient chart. When the oncologist opens it, the case context is already loaded and they can ask in plain language, without leaving the workflow or typing a single field.

The Marco assistant open inside the patient chart: the physician asks about second-line options and clinical trials available in the country.

Why evidence doesn't reach the point of care

The knowledge exists. The failure point is the moment of decision.

Evidence moves faster than the protocol

Approvals, actionable biomarkers and eligibility criteria change continuously. The institutional protocol falls behind without anyone noticing.

Looking it up costs clinical time, so it doesn't happen

Opening another tab competes with the exam room. The lookup ends up happening only in the cases that already felt uncertain.

What does happen, happens outside the perimeter

Teams already consult general-purpose assistants with patient data. No control over sources, no traceability. The institution didn't choose that risk, but it has it.

Marco in the patient chart

Four steps, none of them the physician's job.

The chart opens and the context loads

Marco receives the patient's clinical context. Nothing to copy, paste or summarize.

The physician asks in plain language

About the chart or about the evidence. “What are the second-line options?” is a valid question, because Marco already knows the case.

Marco answers with the source in view

Guidelines, clinical trials, primary literature and regulatory registries, cross-checked against the institutional protocol when available.

The consultation is logged

With its context, its answer and its references. Auditable, without the physician documenting anything extra.

Marco doesn't add one more tool to the physician's desktop. It occupies the only place where looking something up costs nothing: the chart that is already open.

One widget, three benefits

What each stakeholder in the institution gains.

The oncologist

  • Evidence on their own case in seconds, without leaving the chart or typing the context.
  • Backing for the tumor board, with the references already organized.
  • Zero training and no change to how they work.

Medical leadership

  • Less variability between clinicians in the same service.
  • Every decision with its rationale logged and verifiable.
  • Your own institutional protocol built into the answer engine.

The institution

  • Appropriateness of high-cost therapies against criteria and indication.
  • Documented backing for payer audits.
  • Consultations happen inside, not in tools outside the perimeter.

Against what's already in the service

The difference isn't the evidence. It's that Marco knows which patient this is.

Traditional clinical reference General-purpose AI assistant Marco in the patient chart
Knows the patient's case No Only if the physician types it Yes, loaded automatically
Cited, verifiable source Yes Variable Yes, on every answer
Data under institutional control Not applicable No Yes, protected session
Traceable log for audit No No Yes
Inside the workflow No No Yes, inside the chart
Security and compliance ISO 27001 SOC 2 GDPR EU AI Act alignment in progress

How it starts

From first meeting to pilot, with no development on your side.

Demo with your own cases

A session using anonymized cases from your own service. The clinical team sees the product against their reality, not a generic example.

Widget enablement

Integration with your EHR vendor. No development on the institution's side and no training for the medical staff.

Pilot with indicators

Scope, baseline and metrics agreed with medical leadership before starting, and a review at close against those same indicators.

Get started

Let's look at Marco on cases from your own service.

A session with anonymized cases from your institution, with your clinical team present.

Email sales@marco.care
Update cookies preferences